iRhythm Technologies, Inc.
NASDAQ:IRTCMedical - Devices
+$0.36 today
- Market cap
- $3.19B
- Beta
- 1.28
- P/E (TTM)
- -119.5
- EPS (TTM)
- -$0.85
Volume 1.20M
Average 0.52M
IRTC Depreciation & Amortization
Non-cash asset write-downs added back to net income because no cash left the business.
iRhythm Technologies, Inc.NASDAQ: IRTC
Depreciation & Amortization · Q3 FY2026 · quarter ended Sep 2026
Depreciation & amortization declines year over year
Q3 FY2026 depreciation & amortization of $55K fell 99.2% year over year, behind the -23.8% change in trailing-twelve-month depreciation & amortization. Sequentially, it fell 99.2% from the prior quarter. Over 3 fiscal years it compounded at +10.5% a year.
Context
- Depreciation & amortization amounted to 3.5% of revenue in FY2025, down 0.8 pp from a year earlier.
- Depreciation & amortization increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -99.2% toward the trailing-twelve-month pace of -23.8%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the cash flow
- Latest · FY2025
- 26.48M USD
- Year-over-year change
- +2.7%
- 4-year CAGR
- +12.4%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 26.48M | +2.7% |
| FY2024 | 2024-12-31 | 25.78M | +16.4% |
| FY2023 | 2023-12-31 | 22.14M | +12.9% |
| FY2022 | 2022-12-31 | 19.61M | +18.2% |
| FY2021 | 2021-12-31 | 16.59M | — |
Depreciation & Amortization vs competitors
How IRTC compares with its peers on the latest reported figures
- IRTC's LTM Sep 2026 depreciation & amortization of $20.08M is the 5th largest of the 7 companies compared; the peer median is $42.43M.
- Its year-over-year change of -23.8% is the lowest of 7, against a peer median of +0.4%.
- Depreciation & amortization amounts to 2.4% of revenue for IRTC, versus a peer median of 5.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jul 2026 | $2.85B | -3.4% | +3.1% | 7.6% | |
| LTM Jun 2026 | $1.41B | +7.5% | +6.4% | 6.7% | |
| LTM Sep 2026 | $64M | +11.3% | -10.1% | 4.2% | |
| LTM Jun 2026 | $20.86M | +4.2% | +20.6% | 3.7% | |
| LTM Sep 2026 | $20.08M | -23.8% | +10.5% | 2.4% | |
| LTM Jun 2026 | $17.14M | -10.1% | -10.4% | 1.1% | |
| LTM Jan 2026 | $8.22M | -14.7% | — | 9.8% | |
| Peer median (excluding IRTC) | $42.43M | +0.4% | +3.1% | 5.5% | |
Competitors are the stored peer set for IRTC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (101.36M) | (116.16M) | (123.41M) | (113.29M) | (44.55M) |
| Depreciation & Amortization | 16.59M | 19.61M | 22.14M | 25.78M | 26.48M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 54.53M | 57.74M | 77.2M | 75.98M | 88.28M |
| Change in Working Capital | (46.23M) | (65.51M) | (102.05M) | (99.12M) | (91.7M) |
| Accounts Receivables | (53.57M) | (61.84M) | (81.19M) | (91.92M) | (95.43M) |
| Inventory | (4.96M) | (5.11M) | 979K | (224K) | (8.51M) |
| Accounts Payables | 6.14M | (2.99M) | (1.97M) | 0 | 28.04M |
| Other Working Capital | 6.17M | 4.43M | (19.86M) | (6.97M) | (15.8M) |
| Other Non-Cash Items | 38.72M | 81.3M | 76M | 114.04M | 102.35M |
| Operating Cash Flow | (37.75M) | (23.01M) | (50.1M) | 3.39M | 80.86M |
| Capital Expenditures | (28.07M) | (29.83M) | (40.42M) | (48.94M) | (46.34M) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | (122.18M) | (188.57M) | (167.29M) | (175.24M) | (468.41M) |
| Sales of Investments | 255.52M | 165.97M | 206.5M | 101.2M | 237.7M |
| Other Investing Activities | 0 | 0 | 0 | (15M) | 0 |
| Investing Cash Flow | 105.26M | (52.43M) | (1.21M) | (122.98M) | (277.06M) |
| Debt Repayment | (11.67M) | 13.53M | 0 | 619.84M | 0 |
| Common Stock Issued | 8.94M | 0 | 0 | 8.47M | 12.61M |
| Common Stock Repurchased | 0 | 0 | 0 | (25M) | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (25.85M) | 13.18M | 8.82M | (91.93M) | 0 |
| Financing Cash Flow | (28.58M) | 26.72M | 8.82M | 511.38M | 12.61M |
| Effect of Forex Changes | 0 | 0 | (169K) | (6K) | 1K |
| Net Change in Cash | 38.93M | (48.73M) | (42.66M) | 391.78M | (183.59M) |
| Free Cash Flow | (65.82M) | (52.84M) | (90.53M) | (45.55M) | 34.52M |
iRhythm Technologies, Inc.
NASDAQ:IRTC
Intrinsic Alpha fair value
Locked
Current Price
$94.87
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.